{"nct_id":"NCT01530334","title":"Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment","status":"COMPLETED","status_verified_date":"2016-01","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2014-07","primary_completion_date_type":"ACTUAL","completion_date":"2014-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}